Contego Medical's portfolio of angioplasty balloons and stents embodying the Integrated Embolic
Protection(TM) filter platform represents a breakthrough technology, which we believe will help endovascular interventionalists reduce the risk of stroke and other procedural complications," said Doug Reed MD , General Partner of Hatteras Venture Partners.
Certain high-risk situations necessitate use of an embolic
protection device because an embolic
event is more likely to occur," said Mark A.
NEW ORLEANS -- Carotid stenting with the aid of an embolic
protection device produced clinical outcomes that compared "extremely favorably" to conventional surgical endarterectomy in a large, multicenter trial involving high-risk patients, Dr.
Ansel also commented, "The SpideRX Device is unique in that it allows physicians to utilize their own wire system of choice, leading to consistent success in placing the embolic
protection device during carotid interventions.
TEL AVIV, Israel, December 17, 2010 /PRNewswire/ -- InspireMD, developer of the novel MGuard(TM), a combination of a coronary stent merged with an embolic
protection specifically designed for Acute MI (AMI) patients, received significant exposure at the ICI, Innovations in Interventional Cardiology, meeting this week in Tel-Aviv.
Innovative Cardiovascular Solutions (ICS) is pleased to introduce the Emblok Embolic
Protection Catheter to the medical device community.
particles, which may include thrombus, atheroma and lipids, may become dislodged by surgical or catheter manipulations and enter the bloodstream.
GeNeuron is currently investigating several liquid embolic
agents and also anticipates licensing the delivery platform to other device companies who market liquid embolic
One of these two specimens had been embolized with polyvinyl alcohol (PVA) prior to resection, and it was selected to compare the nature of the different embolic
23, 2015 /PRNewswire/ --Summary GlobalData's Medical Devices sector report, "Peripheral Embolic
Protection Devices - Pipeline Review, 2015" provides an overview of Peripheral Embolic
Protection Devices currently in pipeline stage.
Boehringer Ingelheim announces that the first patient has been enrolled in the RE-SPECT ESUS phase III study to investigate the efficacy and safety of dabigatran etexilate for the prevention of recurrent Embolic
Stroke of Undetermined Source, also called ESUS.
Latest Generation Device in Embolic
Capture and Removal for Reducing Stroke during TAVR Procedures